Further, we found that the significantly positive cis‐effect of TIAM1 was also observed on the mRNA and protein levels in the CPTAC BC cohort, respectively[11] (Spearman's rho > 0.3, p < 0.05) (Figure S5A, Supporting Information). Here, TIAM1 is linked to breast cancer.